7.89
price down icon8.47%   -0.73
after-market アフターアワーズ: 8.10 0.21 +2.66%
loading

Replimune Group Inc (REPL) 最新ニュース

pulisher
04:36 AM

Teacher Retirement System of Texas Takes $189,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

04:36 AM
pulisher
Apr 01, 2025

Replimune Group (NASDAQ:REPL) Trading Down 7.6%What's Next? - MarketBeat

Apr 01, 2025
pulisher
Mar 30, 2025

Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Swiss National Bank - Defense World

Mar 30, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Has $6.16 Million Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Mar 25, 2025
pulisher
Mar 22, 2025

Victory Capital Management Inc. Purchases Shares of 44,880 Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Replimune Group, Inc. (NASDAQ:REPL) Holdings Cut by AlphaQuest LLC - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Replimune Group, Inc. (NASDAQ:REPL) Receives $19.43 Average Price Target from Analysts - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Arizona State Retirement System Invests $156,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Mar 17, 2025
pulisher
Mar 12, 2025

Financial Metrics Check: Replimune Group Inc (REPL)’s Ratios for Trailing Twelve Months - The Dwinnex

Mar 12, 2025
pulisher
Mar 07, 2025

Replimune Group Appoints New Director, Grants Stock Options By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 07, 2025

Replimune Group Appoints New Director, Grants Stock Options - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Replimune Group Appoints Michael Goller To Board, Increases Board Size To Ten -March 07, 2025 at 05:04 pm EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 07, 2025
pulisher
Mar 07, 2025

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) -March 07, 2025 at 04:11 pm EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 06, 2025

Rhumbline Advisers Grows Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Replimune Raises $55 Million To Advance Its Oncolytic Immunotherapy Programs - Bain Capital

Mar 06, 2025
pulisher
Mar 05, 2025

New York State Common Retirement Fund Purchases 31,231 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Mar 05, 2025
pulisher
Mar 01, 2025

JPMorgan Chase & Co. Increases Replimune Group (NASDAQ:REPL) Price Target to $18.00 - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Replimune Group (NASDAQ:REPL) Price Target Raised to $18.00 - Defense World

Mar 01, 2025
pulisher
Feb 24, 2025

Replimune Group (NASDAQ:REPL) Stock Price Up 6.1%What's Next? - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

Replimune Group, Inc. (NASDAQ:REPL) Receives $19.29 Average Price Target from Brokerages - Defense World

Feb 23, 2025
pulisher
Feb 20, 2025

Replimune Group, Inc. (NASDAQ:REPL) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Replimune Group, Inc. (NASDAQ:REPL) Short Interest Update - MarketBeat

Feb 20, 2025
pulisher
Feb 18, 2025

Replimune's SWOT analysis: oncolytic immunotherapy stock poised for FDA approval - Investing.com

Feb 18, 2025
pulisher
Feb 17, 2025

Possible Bearish Signals With Replimune Group Insiders Disposing Stock - Simply Wall St

Feb 17, 2025
pulisher
Feb 17, 2025

Leerink Partnrs Predicts Weaker Earnings for Replimune Group - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

FY2025 EPS Estimates for Replimune Group Lowered by Wedbush - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Replimune Group (NASDAQ:REPL) Announces Quarterly Earnings Results - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

HC Wainwright Forecasts Strong Price Appreciation for Replimune Group (NASDAQ:REPL) Stock - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

Replimune stock target raised to $22 at H.C. Wainwright - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Replimune stock target raised to $22 at H.C. Wainwright By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 12, 2025

Replimune: A Misunderstood Contender In Oncolytics (NASDAQ:REPL) - Seeking Alpha

Feb 12, 2025
pulisher
Feb 12, 2025

Wedbush Raises Replimune Group's Price Target to $19 From $16, Keeps Outperform Rating - Marketscreener.com

Feb 12, 2025
pulisher
Feb 12, 2025

Replimune Group Inc. (REPL) reports earnings - Quartz

Feb 12, 2025
pulisher
Feb 12, 2025

Replimune Group, Inc. SEC 10-Q Report - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

Feb 12, 2025
pulisher
Feb 12, 2025

FDA Fast-Tracks Replimune's Melanoma Treatment as Cash Reserves Hit $536M in Q3 Report - StockTitan

Feb 12, 2025
pulisher
Feb 10, 2025

Top Wealth Group Holding Ltd (TWG)’s financial ratios: A comprehensive overview - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

Metric Analysis: Nvni Group Ltd (NVNI)’s Key Ratios in the Limelight - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Feb 10, 2025
pulisher
Feb 08, 2025

How to Take Advantage of moves in (REPL) - Stock Traders Daily

Feb 08, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
大文字化:     |  ボリューム (24 時間):